Non-interventional study.
Sponsors
Universitätsklinikum Freiburg, Abteilung Nuklearmedizin, F. HOFFMANN-LA ROCHE LTD, GlaxoSmithKline
Conditions
C75.9Patients diagnosed with locally advanced/metastatic non-small cell lung cancer (NSCLC) after prior chemotherapy. Patients with epidermal growth factor receptor (EGFR) activating mutations or anaplastic lymphoma kinase (ALK)- positive tumor mutations should also have received targeted therapy
NSCLCPulmonary Disease, Chronic Obstructive
Unknown Phase
Airway Limitation Study: Study In Primary Care Centers Of Chronic Bronchitis In Long-Term Cigarette Smokers Of At Least 40 Years Of Age With Symptoms Of Cough And Shortness Of Breath
CompletedNCT00442468
Start: 2007-04-30End: 2007-09-30Updated: 2013-01-10
PET/CT imaging and dosimetry as predictive factors for treatment response of the 177Lu-DOTA-TATE therapy
Active, not recruitingDRKS00004376
Start: 2012-10-01Target: 12Updated: 2025-04-07
IMReal
RecruitingLBCTR2020033423
Start: 2020-04-01Target: 10Updated: 2026-02-02